(Q45282214)

11 December 2017

Polycystic ovarian syndrome: marked differences between endocrinologists and gynaecologists in diagnosis and management (English)

1 reference

11 December 2017

3

1 reference

11 December 2017

5

1 reference

11 December 2017

Andrea J Cussons

1

1 reference

PubMed ID

15730409

11 December 2017

Bronwyn G A Stuckey

series ordinal

2

1 reference

PubMed ID

15730409

11 December 2017

Valerie Burke

series ordinal

4

1 reference

11 December 2017

1 March 2005

1 reference

11 December 2017

Clinical Endocrinology

1 reference

11 December 2017

62

1 reference

11 December 2017

3

1 reference

11 December 2017

289-295

1 reference

A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.

11 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02208.X

Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02208.X

Polycystic Ovary Syndrome (PCOS): Arguably the Most Common Endocrinopathy Is Associated with Significant Morbidity in Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02208.X

Differences between endocrine surgeons and endocrinologists in the management of non-toxic multinodular goitre

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02208.X

Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02208.X

Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02208.X

Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02208.X

Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02208.X

Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02208.X

Polycystic ovaries--a common finding in normal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02208.X

An evaluation of the inter-observer and intra-observer variability of the ultrasound diagnosis of polycystic ovaries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02208.X

The role of lifestyle modification in polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02208.X

Effects of two antiandrogen treatments on hirsutism and insulin sensitivity in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02208.X

A modern medical quandary: polycystic ovary syndrome, insulin resistance, and oral contraceptive pills

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02208.X

Should patients with polycystic ovarian syndrome be treated with metformin?: an enthusiastic endorsement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02208.X

A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02208.X

Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02208.X

Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02208.X

Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02208.X

Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02208.X

New concepts in human sperm-zona pellucida interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02208.X

Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02208.X

Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02208.X

A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02208.X

Clomid versus metformin for ovulation induction--let's not have any "hanging chads"!

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02208.X

Effect of rosiglitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02208.X

High ovulatory rates with use of troglitazone in clomiphene-resistant women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02208.X

Sibutramine has a positive effect on clinical and metabolic parameters in obese patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02208.X

Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02208.X

Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02208.X

Polycystic ovary syndrome and endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02208.X

Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: a prospective parallel randomized double-blind placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02208.X

10.1111/J.1365-2265.2004.02208.X

21 January 2018

Identifiers

DOI

1 reference

11 December 2017

1 reference

PubMed ID

15730409